Pradžia › Krūties ligos › Texas
Krūties ligos klinikiniai tyrimai Texas
7 tyrimai dėl Krūties ligos ieško dalyvių vietose Texas.
Miestai Texas
Oficialus tyrimo tekstas (anglų kalba)
ATUSA Ultrasound Diagnostic Imaging for Breast Lesions Evaluation (AUDIBLE) - iSono Health
- Cypress Innovative Breast Care Center, Cypress
Renkami dalyviaiStebimasis tyrimas
Amžius nuo 18 iki 94 · Moterims · Atnaujinta 2026-09-17 · NCT07505797Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
- University of Texas MD Anderson Cancer Center, Houston
Renkami dalyviai1/2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-09 · NCT05386108A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer
- Research Site, Fort Worth
- Research Site, Kingwood
Renkami dalyviai3 fazė
Amžius nuo 18 iki 130 · Visoms lytims · Atnaujinta 2026-09-08 · NCT07647328IMPACT: Improving Maternal Postpartum Access to Care Through Telemedicine
- Parkland Hospital, Dallas
Renkami dalyviaiLaukiami sveiki savanoriai
Amžius 18 ir vyresni · Moterims · Atnaujinta 2026-09-02 · NCT06218355First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
- Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas
- University of Texas Southwestern, Dallas
- University of Texas MD Anderson Cancer Center, Houston
- ir dar 1
Renkami dalyviai1/2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-07-07 · NCT05768139Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
- The University of Texas MD Anderson Cancer Center, Houston
- START, San Antonio
Renkami dalyviai1/2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-06-23 · NCT06993844Hormones, Outcomes, and Pain Pathways in Exercise Study
- University of Houston, Houston
Renkami dalyviai1 fazėLaukiami sveiki savanoriai
Amžius nuo 18 iki 60 · Moterims · Atnaujinta 2026-06-02 · NCT07579182Iš ClinicalTrials.gov, duomenys gauti 2026-10-04. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.